Additionally, cytotoxic T-lymphocyte associated protein 4 (CTLA4), which is an important T-cell immune regulation factor and a well-known immune checkpoint target in cancer immunotherapy, was also upregulated in high PFKP cancer samples. Here, CTLA4 is linked to cancer.